FFCP PHASE1:Mm9::chr19:8742249..8742252,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=135|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr19:8742249..8742252,+|id=chr19:8742249..8742252,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002021!1.93e-10!10;UBERON:0000411!1.93e-10!10;UBERON:0001950!1.93e-10!10;UBERON:0002791!3.21e-10!29;UBERON:0003528!3.21e-10!29;UBERON:0001893!3.21e-10!29;UBERON:0002780!5.98e-09!39;UBERON:0001890!5.98e-09!39;UBERON:0006240!5.98e-09!39;UBERON:0000956!6.03e-09!21;UBERON:0001869!6.03e-09!21;UBERON:0000203!6.03e-09!21;UBERON:0003080!1.10e-08!40;UBERON:0002020!1.67e-08!34;UBERON:0002619!2.03e-08!17;UBERON:0003056!3.44e-08!49;UBERON:0002616!8.88e-07!49|ontology_enrichment_uberon_v019_2=UBERON:0001851,5.07e-23,1;UBERON:0005889,5.07e-23,1;UBERON:0002021,2.31e-20,10;UBERON:0000411,2.31e-20,10;UBERON:0001950,2.31e-20,10;UBERON:0002619,2.19e-12,17;UBERON:0000956,3.37e-10,21;UBERON:0001869,3.37e-10,21;UBERON:0000203,3.37e-10,21;UBERON:0003528,1.28e-07,29;UBERON:0002791,1.28e-07,29;UBERON:0001893,1.28e-07,29|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.457500602818626,0.502617408451458,0.347648640384553,1.27857728665165,0,0.324482526135515,0,0,0,0,0,0,0,0.150704817835715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.630869845692382,0,0,0.264450566663544,0,0,0,0,0,0,0,0,0.251335208800269,0,0,0,0,0.199141273254367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.108005340821801,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241584120826006,0,0,0,0,0.129920822977795,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.14579102687879,3.09335728218638,0.685082519770642,0,0,0,0.906284817968409,1.03552062350364,0,0,0,0.243106717068294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154936841185966,0,0,0,0.214871054048298,0.191288332068843,0,0|short_description=p@chr19:8742249..8742252,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=135 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr19:8742249..8742252,+ | |||
|description=CAGE_peak_at_chr19:8742249..8742252,+ | |||
|id=chr19:8742249..8742252,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002021!1.93e-10!10;UBERON:0000411!1.93e-10!10;UBERON:0001950!1.93e-10!10;UBERON:0002791!3.21e-10!29;UBERON:0003528!3.21e-10!29;UBERON:0001893!3.21e-10!29;UBERON:0002780!5.98e-09!39;UBERON:0001890!5.98e-09!39;UBERON:0006240!5.98e-09!39;UBERON:0000956!6.03e-09!21;UBERON:0001869!6.03e-09!21;UBERON:0000203!6.03e-09!21;UBERON:0003080!1.10e-08!40;UBERON:0002020!1.67e-08!34;UBERON:0002619!2.03e-08!17;UBERON:0003056!3.44e-08!49;UBERON:0002616!8.88e-07!49 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001851,5.07e-23,1;UBERON:0005889,5.07e-23,1;UBERON:0002021,2.31e-20,10;UBERON:0000411,2.31e-20,10;UBERON:0001950,2.31e-20,10;UBERON:0002619,2.19e-12,17;UBERON:0000956,3.37e-10,21;UBERON:0001869,3.37e-10,21;UBERON:0000203,3.37e-10,21;UBERON:0003528,1.28e-07,29;UBERON:0002791,1.28e-07,29;UBERON:0001893,1.28e-07,29 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.457500602818626,0.502617408451458,0.347648640384553,1.27857728665165,0,0.324482526135515,0,0,0,0,0,0,0,0.150704817835715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.630869845692382,0,0,0.264450566663544,0,0,0,0,0,0,0,0,0.251335208800269,0,0,0,0,0.199141273254367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.108005340821801,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241584120826006,0,0,0,0,0.129920822977795,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.14579102687879,3.09335728218638,0.685082519770642,0,0,0,0.906284817968409,1.03552062350364,0,0,0,0.243106717068294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154936841185966,0,0,0,0.214871054048298,0.191288332068843,0,0 | |||
|short_description=p@chr19:8742249..8742252,+ | |||
}} |
Latest revision as of 13:40, 4 August 2015
Short description: | p@chr19:8742249..8742252, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr19:8742249..8742252, + |
Coexpression cluster: | MCL_coexpression_mm9:135 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cortex | 5.07e-23 | 1 |
zygote cortex | 5.07e-23 | 1 |
occipital lobe | 2.31e-20 | 10 |
visual cortex | 2.31e-20 | 10 |
neocortex | 2.31e-20 | 10 |
regional part of cerebral cortex | 2.19e-12 | 17 |
cerebral cortex | 3.37e-10 | 21 |
cerebral hemisphere | 3.37e-10 | 21 |
pallium | 3.37e-10 | 21 |
brain grey matter | 1.28e-07 | 29 |
regional part of telencephalon | 1.28e-07 | 29 |
telencephalon | 1.28e-07 | 29 |